Liberty Health Sciences to Bring Mary’s Medicinals Cannabis Products to Florida Patients

Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Liberty Health Sciences Inc. Signs Exclusive Licensing and Raw Materials Agreement With Mary’s Medicinals to Provide Floridians With Range of Award-Winning Cannabis Products

 

TORONTO, Oct. 24, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced a partnership with Colorado-based MM Technology Holdings, LLC (“Mary’s”) to bring its award-winning line of Mary’s Medicinals® cannabis products to the Florida market. Under the three-year agreement, Liberty will produce and distribute a suite of effective and reliable products from Mary’s under license in the State of Florida to further optimize patient care. The agreement is subject to approval by the Florida Department of Health, Office of Medical Marijuana Use as is required under Florida law.

Our goal is to provide the best available medical cannabis products to our patients and Mary’s has a proven track record of success in the space. We’re very pleased to be partnering with the company to bring their award-winning products to the Florida market and offer alternative methods of using medical cannabis. This partnership further ensures our patients have access to the most effective medicine on the market today.

George Scorsis, CEO and Director of Liberty

Liberty is committed to delivering high-quality, clean and safe pharmaceutical grade cannabis and this agreement with Mary’s elevates the number of cutting-edge products available to its patients. Best known as the developer and exclusive distributor of the award-winning Transdermal Cannabis Patch, Mary innovates at the intersection of technology and horticulture and is transforming how people view and utilize cannabis, developing products that maximize the benefits of cannabinoids, terpenes and other plant nutrients. The agreement with Mary’s allows Liberty to license and produce the following products:

  • Mary’s Medicinals® Transdermal patches
  • Mary’s Medicinals® Transdermal gels
  • Mary’s Medicinals® Transdermal/topical compounds
  • Mary’s Medicinals® Capsules
  • Mary’s Medicinals® Tinctures
  • Mary’s Medicinals® Muscle Freeze
  • Mary’s Medicinals® Vape Pens
  • Mary’s Medicinals® Distillates

Mary’s creates effective and natural pain-relief products, utilizing clinically tested, clean and accurate delivery methods. Most importantly, the company is dedicated to developing innovative products, which have garnered numerous accolades including 2014 Invention of the Year in the Cannabis Business Awards, Most Innovative Product at the CannAwards and Best New Product at the High Times Cannabis Cup.

Mary’s and Liberty share a patient-first mentality, which makes our partnership a natural fit. We’re pleased to join forces with the team at Liberty to help bring new forms of relief to Florida patients.

Lynn Honderd, CEO of Mary’s

For more information on Liberty, please visit www.libertyhealthsciences.com

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

About Mary’s Medicinals

Best known as the developer and exclusive distributor of the award-winning transdermal cannabis patch, Mary’s Medicinals is a wellness company innovating at the intersection of engineering, technology and horticulture. Mary’s mission is to transform how people view and utilize cannabis by developing products that isolate the benefits of cannabinoids and other vital plant extracts for optimum patient care. All Mary’s Medicinals products have the Seal of Approval from The Realm of Caring. For more information, please visit www.marysmedicinals.com.

Original press release: http://www.newswire.ca/news-releases/liberty-health-sciences-inc-signs-exclusive-licensing-and-raw-materials-agreement-with-marys-medicinals-to-provide-floridians-with-range-of-award-winning-cannabis-products-652713163.html

For fact-based information on Liberty Health Sciences, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter